UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 370

Sortiert nach

Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management

Cancer treatment reviews, 2017-07, Vol.58, p.70-76

2017

Volltextzugriff (PDF)

New modalities of cancer treatment for NSCLC: focus on immunotherapy

Cancer management and research, 2014-01, Vol.6 (default), p.63-75

Davies, Marianne

2014

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2018-07, Vol.6 (1), p.75-75, Article 75

2018

Volltextzugriff (PDF)

Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events

ImmunoTargets and therapy, 2017-01, Vol.6, p.51-71

2017

Volltextzugriff (PDF)

Every story has two sides: evaluating information processing and ecological dynamics perspectives of focus of attention in skill acquisition

Frontiers in sports and active living, 2023-05, Vol.5, p.1176635-1176635

2023

Volltextzugriff (PDF)

Challenges associated with the integration of immuno-oncology agents in clinical practice

BMC medical education, 2022-11, Vol.22 (1), p.1-781, Article 781

2022

Volltextzugriff (PDF)

Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners

1st ed. 2019., 2019

Volltextzugriff (PDF)

Recent legislative and regulatory developments of interest to energy lawyers

Alberta law review, 2023-12, Vol.61 (2), p.483-516

2023

Volltextzugriff (PDF)

Acute and Long-term Adverse Events Associated With Checkpoint Blockade

Seminars in oncology nursing, 2019-10, Vol.35 (5), p.150926-150926, Article 150926

Davies, Marianne

2019

Volltextzugriff (PDF)

Management of Pneumonitis and Neuropathy in Patients Receiving PD-1-Based Therapy for Non-Small-Cell Lung Cancer

JCO oncology practice, 2020-02, Vol.16 (2_suppl), p.4s-9s

2020

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma

Journal for immunotherapy of cancer, 2022-05, Vol.10 (5), p.e003956

2022

Volltextzugriff (PDF)

PD-1/PD-L1 Inhibitors for Non-Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management

Journal of the advanced practitioner in oncology, 2019-03, Vol.10 (Suppl 1), p.21-35

Davies, Marianne J

2019

Volltextzugriff (PDF)

Perceptions of roles, practice patterns, and professional growth opportunities: broadening the scope of advanced practice in oncology

Clinical journal of oncology nursing, 2012-08, Vol.16 (4), p.382

2012

Volltextzugriff (PDF)

Evidence-Based Antiemetic Decision Tool for Management of Postoperative Nausea and Vomiting in Patients at High Risk of QT Prolongation and Patients Receiving Neurotransmitter-Modulating Medications

AANA journal, 2020-08, Vol.88 (4), p.312-318

2020

Volltextzugriff (PDF)

Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer

Cancer treatment reviews, 2020-04, Vol.85, p.101979-101979, Article 101979

2020

Volltextzugriff (PDF)

The alarm bell is sounding and the regulator is at the door: Emergency response, reporting, and investigations in the age of heightened compliance monitoring and enforcement

Alberta law review, 2017-12, Vol.55 (2), p.367-438

2017

Volltextzugriff (PDF)

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

Journal of palliative medicine, 2015-11, Vol.18 (11), p.962

2015

Volltextzugriff (PDF)

Targeted Therapies in Lung Cancer

1, 2019

Volltextzugriff (PDF)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Journal for immunotherapy of cancer, 2017-11, Vol.5 (1), p.95-28, Article 95

2017

Volltextzugriff (PDF)

Learning and Expertise in Mineral Exploration Decision-Making: An Ecological Dynamics Perspective

International journal of environmental research and public health, 2021-09, Vol.18 (18), p.9752

2021

Volltextzugriff (PDF)

Nivolumab and ipilimumab in advanced non small cell lung cancer previously treated with PD1 axis inhibition

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9121-9121

2023

Volltextzugriff (PDF)

NSCLC: Integrating the “Yale model shared decision-making solution” into the practice setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7054-7054

2020

Volltextzugriff (PDF)

Can’t jump, won’t jump: Affordances of the horse-rider dyad underpin skill adaptation in showjumping using a constraints-led approach

International journal of sports science & coaching, 2023-08, Vol.18 (4), p.1313-1319

2023

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(336)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(193)
MEDLINE
(149)
Ovid SocietyJournals and Single Titles
(130)
Ingenta
(115)
Wiley Online Library Journals
(96)
Publisher website
(87)
IngentaConnect Journals
(51)
Access via ScienceDirect (Elsevier)
(49)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(41)
Wiley Online Library
(25)
Oxford Journals
(19)
Ebook Central Perpetual and DDA
(18)
eBooks on EBSCOhost
(18)
JSTOR
(15)
SpringerLink
(15)
Oxford Journals 2020 Medicine
(14)
Taylor & Francis
(14)
Taylor & Francis Current Content Access
(13)
Access via Taylor & Francis
(13)
BMJ Journals
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management

New modalities of cancer treatment for NSCLC: focus on immunotherapy

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events

Every story has two sides: evaluating information processing and ecological dynamics perspectives of focus of attention in skill acquisition

Challenges associated with the integration of immuno-oncology agents in clinical practice

Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners

Recent legislative and regulatory developments of interest to energy lawyers

Acute and Long-term Adverse Events Associated With Checkpoint Blockade

Management of Pneumonitis and Neuropathy in Patients Receiving PD-1-Based Therapy for Non-Small-Cell Lung Cancer

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma

PD-1/PD-L1 Inhibitors for Non-Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management

Perceptions of roles, practice patterns, and professional growth opportunities: broadening the scope of advanced practice in oncology

Evidence-Based Antiemetic Decision Tool for Management of Postoperative Nausea and Vomiting in Patients at High Risk of QT Prolongation and Patients Receiving Neurotransmitter-Modulating Medications

Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer

The alarm bell is sounding and the regulator is at the door: Emergency response, reporting, and investigations in the age of heightened compliance monitoring and enforcement

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

Targeted Therapies in Lung Cancer

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Learning and Expertise in Mineral Exploration Decision-Making: An Ecological Dynamics Perspective

Nivolumab and ipilimumab in advanced non small cell lung cancer previously treated with PD1 axis inhibition

NSCLC: Integrating the “Yale model shared decision-making solution” into the practice setting

Can’t jump, won’t jump: Affordances of the horse-rider dyad underpin skill adaptation in showjumping using a constraints-led approach

Suchergebnisse filtern